Rockwell Medical(RMTI)
Focus: Rockwell Medical is a public biotechnology company specializing in dialysis products and nephrology therapeutics, with a focused portfolio centered on iron supplementation for renal patients. The company generated $101M in FY 2025 revenue with a market cap implied by ticker RMTI.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Funding Stage
PUBLIC
Open Jobs
2-1 this month
Stable — net -1 jobs in 30d
10 added, 11 removed. Backfill posture.
Should You Work at Rockwell Medical?
AI assessmentRockwell Medical offers stable, niche nephrology expertise with a protected commercial asset, but presents limited innovation exposure and concerning profitability trajectory for career-minded professionals.
Why Work Here
- Peak-stage commercial product (TRIFERIC AVNU with ferric pyrophosphate citrate) protected until 2029, providing 5+ years of market exclusivity
Data completeness
7/9 — Strong
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
3 in 5yr
TRIFERIC
Hiring
Stable
Revenue
$101M
Key Products
Peak2.8yr
Lead franchise with 4+ years of patent protection; primary commercial driver for the company.
Help build intelligence for Rockwell Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.